Document is current
Any future updates will be listed below
-
Authors
Savarino, Edoardo http://orcid.org/0000-0002-3187-2894
Bhatia, Shobna http://orcid.org/0000-0001-6132-0356
Roman, Sabine http://orcid.org/0000-0002-3388-0660
Sifrim, Daniel
Tack, Jan
Thompson, Sarah K.
Gyawali, C. Prakash
- License Information
-
More Information
Article History
Accepted: 1 April 2022
First Online: 5 May 2022
Competing interests
: E.S. has served as speaker for AbbVie, AGPharma, Alfasigma, EG Stada Group, Fresenius Kabi, Grifols, Janssen, Innovamedica, Malesci, Medtronic, Novartis, Pfizer, Reckitt Benckiser, Sandoz, SILA, Sofar, Takeda and Unifarco; has served as consultant for Alfasigma, Amgen, Biogen, Bristol-Myers Squibb, Celltrion, Diadema Farmaceutici, Falk, Fresenius Kabi, Janssen, Merck & Co., Reckitt Benckiser, Regeneron, Sanofi, Shire, SILA, Sofar, Synformulas GmbH, Takeda and Unifarco; and has received research support from Reckitt Benckiser, SILA, Sofar and Unifarco. S.B. has served as speaker for Medtronic. S.R. has served as consultant for Reckitt Benckiser and Dr Falk Pharma; and has received research support from Medtronic and Diversatek Healthcare. D.S. has served as consultant for Reckitt Benckiser UK, Jinshan Technology China and Alfasigma Italy. J.T. has served on the speaker bureau for Abbott, Mylan and Takeda; has served as consultant for Arena, Bayer, Falk, Takeda and Truvion pharmaceuticals; and has received research support from Shire, Sofar and Takeda. S.K.T. has served as a consultant for Medtronic. C.P.G. has served as speaker for Medtronic, Takeda and Johnson&Johnson, and has served as consultant for Medtronic, Diversatek, Takeda and Ironwood.
